These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17503567)

  • 1. [The expression of p53 protein in patients with multiple myeloma].
    Marković O; Marisavljević D; Cemerikić V; Perunicić M; Colović M
    Srp Arh Celok Lek; 2007; 135(1-2):43-7. PubMed ID: 17503567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of cyclin D1 and p53 in multiple myeloma: relationship to proliferative activity and prognostic significance.
    Markovic O; Marisavljevic D; Cemerikic V; Suvajdzic N; Milic N; Colovic M
    Med Oncol; 2004; 21(1):73-80. PubMed ID: 15034217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proliferative activity of myeloma cells determined by Ki-67 antibody: biological and clinical significance].
    Marković O; Marisavljević D; Cemerikić V; Vidović A; Bakrac M; Perunicić M; Suvajdzić N; Colović M
    Vojnosanit Pregl; 2005 Jan; 62(1):33-8. PubMed ID: 15715347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance.
    Marković O; Marisavljević D; Cemerikić V; Vidović A; Perunicić M; Todorović M; Elezović I; Colović M
    Med Oncol; 2008; 25(4):451-7. PubMed ID: 18449811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III.
    Niemöller K; Jakob C; Heider U; Zavrski I; Eucker J; Kaufmann O; Possinger K; Sezer O
    J Cancer Res Clin Oncol; 2003 Apr; 129(4):234-8. PubMed ID: 12700896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
    D'Anastasi M; Notohamiprodjo M; Schmidt GP; Dürr HR; Reiser MF; Baur-Melnyk A
    AJR Am J Roentgenol; 2014 Oct; 203(4):854-62. PubMed ID: 25247952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and clinical significance of beta-catenin in multiple myeloma].
    Li J; Zhang DB; Luo SK; Zhao Y; Huang BH; Gu JL
    Ai Zheng; 2007 Sep; 26(9):1010-4. PubMed ID: 17927863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle regulators in multiple myeloma: prognostic implications of p53 nuclear accumulation.
    Pruneri G; Carboni N; Baldini L; Intini D; Colombi M; Bertolini F; Valentini S; Maisonneuve P; Viale G; Neri A
    Hum Pathol; 2003 Jan; 34(1):41-7. PubMed ID: 12605365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
    Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
    Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of
    Deng S; Zhang B; Zhou Y; Xu X; Li J; Sang S; Zhang W
    Contrast Media Mol Imaging; 2018; 2018():4198673. PubMed ID: 30154686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the cell-cycle-related proteins E2F-1, p53, mdm-2, p21waf-1, and Ki-67 in multiple myeloma: correlation with cyclin-D1 immunoreactivity.
    Lai R; Medeiros LJ; Wilson CS; Sun NC; Koo C; McCourty A; Brynes RK
    Mod Pathol; 1998 Jul; 11(7):642-7. PubMed ID: 9688185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of the p53, p21/Waf-1, Rb, p16 and Ki67 proteins in multiple myeloma.
    Kanavaros P; Stefanaki K; Vlachonikolis J; Papalazarou D; Rontogianni D; Arvanitis D; Antonakopoulos G; Gorgoulis V; Bai M; Agnantis NJ
    Anticancer Res; 2000; 20(6B):4619-25. PubMed ID: 11205312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS; Kumar L; Dinda AK; Dawar R
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-67 proliferation index: correlation with prognostic parameters and outcome in multiple myeloma.
    Alexandrakis MG; Passam FH; Kyriakou DS; Dambaki K; Niniraki M; Stathopoulos E
    Am J Clin Oncol; 2004 Feb; 27(1):8-13. PubMed ID: 14758126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics of bone disease in multiple myeloma and clinical significance of monitoring bone metabolic markers].
    Chu B; Lu MQ; Wu MQ; Shi L; Fu LN; Gao S; Fang LJ; Xiang QQ; Bao L
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1424-9. PubMed ID: 27266350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-67 Immunostaining and its Correlation with Microvessel Density in Patients with Mutiple Myeloma.
    Himani B; Meera S; Abhimanyu S; Usha R
    Asian Pac J Cancer Prev; 2016; 17(5):2559-64. PubMed ID: 27268630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma.
    Sheth N; Yeung J; Chang H
    Leuk Res; 2009 Oct; 33(10):1357-60. PubMed ID: 19201468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of miR-21 in multiple myeloma and its clinical significance].
    Zhang TL; Sun L; Wang SM; Meng YS; Xing XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):616-9. PubMed ID: 22739167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of cyclin D1, fibroblast growth factor receptor 3, and p53 immunohistochemistry in plasma cell myeloma treated with a thalidomide-based regimen.
    Kelley TW; Baz R; Hussein M; Karafa M; Cook JR
    Hum Pathol; 2009 Mar; 40(3):405-12. PubMed ID: 19070887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
    Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.